Tan A. Ince

ORCID: 0000-0003-0315-6425 · 4 papers in corpus
2021
Molecular cancer therapeutics ·doi:10.1158/1535-7163.mct-20-0809

Ovarian clear cell carcinoma (OCCC) is a rare, chemo-resistant subtype of ovarian cancer. To identify novel therapeutic targets and combination therapies for OCCC, we subjected a set of patient-derived ovarian cancer cell lines to arrayed h…

2013
PloS one ·doi:10.1371/journal.pone.0080314

The potential role of the cell-of-origin in determining the tumor phenotype has been raised, but not adequately examined. We hypothesized that distinct cells-of-origin may play a role in determining ovarian tumor phenotype and outcome. Here…

article 2008
Histopathology ·doi:10.1111/j.1365-2559.2007.02938.x

Prolongation of ovarian epithelial cancer survival depends on early detection or improved responses to chemotherapy. Gains in either have been modest at best. Understanding the diverse pathogenesis of this disease is critical to early inter…

article 2004
Nature medicine ·doi:10.1038/nm1173

Epithelial ovarian tumors present a complex clinical, diagnostic and therapeutic challenge because of the difficulty of early detection, lack of known precursor lesions and high mortality rates. Endometrioid ovarian carcinomas are frequentl…